Nuformix plc (LON:NFX – Get Free Report)’s stock price hit a new 52-week low during trading on Monday . The company traded as low as GBX 0.15 ($0.00) and last traded at GBX 0.17 ($0.00), with a volume of 3296707 shares. The stock had previously closed at GBX 0.17 ($0.00).
Nuformix Stock Down 0.6 %
The firm has a market capitalization of £1.38 million, a PE ratio of -1.63 and a beta of 1.20. The business’s 50 day simple moving average is GBX 0.18 and its 200 day simple moving average is GBX 0.20. The company has a current ratio of 1.12, a quick ratio of 3.35 and a debt-to-equity ratio of 1.17.
Nuformix Company Profile
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
Featured Articles
- Five stocks we like better than Nuformix
- Compound Interest and Why It Matters When Investing
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- What is a Stock Market Index and How Do You Use Them?
- 2 Option Strategies to Maximize Profits in a Bear Market
- The 3 Best Blue-Chip Stocks to Buy Now
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
